Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - OTHER CURRENT LIABILITIES
Other Current Liabilities IMVT - Immunovant, Inc.
41.2 M
LAST VALUE
29.00%
2 YEAR CAGR
248.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR